Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference newsletter

  Cervical Cancer

  Free Subscription


1 Abdom Radiol (NY)
3 Acta Cytol
1 Aging (Albany NY)
1 Arch Gynecol Obstet
1 Biomed Pharmacother
1 BJR Case Rep
2 BMC Public Health
1 BMJ Open Qual
2 Brachytherapy
1 Cancer Causes Control
1 Cancer Epidemiol
1 Cancer Prev Res (Phila)
1 Chin Med J (Engl)
1 Clin Chim Acta
2 Clin Infect Dis
1 Eur J Cancer Prev
1 Exp Cell Res
1 Front Oncol
1 Georgian Med News
2 Gynecol Oncol
1 Int J Biol Markers
1 Int J Clin Exp Pathol
1 Int J Clin Oncol
1 Int J Equity Health
1 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Legal Med
2 Int J Med Sci
1 Int J Mol Cell Med
3 J Cancer
1 J Clin Med
1 J Geriatr Oncol
1 J Infect Public Health
1 J Womens Health (Larchmt)
1 JAMA Netw Open
1 Med Phys
1 Nurs Health Sci
1 Oncol Lett
1 Radiother Oncol
3 Rev Prat
2 Sex Transm Infect
1 South Afr J HIV Med
1 Taiwan J Obstet Gynecol
1 Virchows Arch
3 Zhonghua Bing Li Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Abdom Radiol (NY)

  1. BAI Z, Shi J, Yang Z, Zeng W, et al
    Quantitative kinetic parameters of primary tumor can be used to predict pelvic lymph node metastasis in early-stage cervical cancer.
    Abdom Radiol (NY). 2020 Sep 15. pii: 10.1007/s00261-020-02762.
    PubMed         Abstract available

    Acta Cytol

  2. TANAKA K, Aoki D, Tozawa-Ono A, Suzuki N, et al
    Comparison of ThinPrep Integrated Imager-Assisted Screening versus Manual Screening of ThinPrep Liquid-Based Cytology Specimens.
    Acta Cytol. 2020;64:486-491.
    PubMed         Abstract available

  3. PETRINI CG, Bastos LB, Duarte G, Dos Santos Melli PP, et al
    Downregulation of IL-2 and IL-23 in Cervical Biopsies of Cervical Intraepithelial Lesions: A Cross-Sectional Study.
    Acta Cytol. 2020;64:442-451.
    PubMed         Abstract available

  4. SATAKE H, Inaba N, Kanno K, Mihara M, et al
    Comparison Study of Self-Sampled and Physician-Sampled Specimens for High-Risk Human Papillomavirus Test and Cytology.
    Acta Cytol. 2020;64:433-441.
    PubMed         Abstract available

    Aging (Albany NY)

  5. WANG J, Wang P, He Y, Liu X, et al
    Graphene oxide inhibits cell migration and invasion by destroying actin cytoskeleton in cervical cancer cells.
    Aging (Albany NY). 2020;12.
    PubMed         Abstract available

    Arch Gynecol Obstet

  6. OUYANG P, Cai J, Gui L, Liu S, et al
    Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Arch Gynecol Obstet. 2020;301:1247-1255.
    PubMed         Abstract available

    Biomed Pharmacother

  7. ZHANG Y, Li X, Zhang J, Mao L, et al
    Novel cellular immunotherapy using NKG2D CAR-T for the treatment of cervical cancer.
    Biomed Pharmacother. 2020;131:110562.
    PubMed         Abstract available


  8. WEYERS S, Garland SM, Cruickshank M, Kyrgiou M, et al
    Cervical cancer prevention in transgender men: a review.
    BJOG. 2020 Sep 15. doi: 10.1111/1471-0528.16503.
    PubMed         Abstract available

  9. YA X, Qian W, Huiqing L, Haixiao W, et al
    Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer: a prospective study.
    BJOG. 2020 Sep 15. doi: 10.1111/1471-0528.16504.
    PubMed         Abstract available

    BJR Case Rep

  10. RUBASINGHAM J, Marzouk S, Madhavan K, Sioftanos G, et al
    Pulmonary sarcoidosis masquerading as metastatic cervical cancer: a pitfall in CT scans and positron emission tomography (PET).
    BJR Case Rep. 2020;6:20190125.
    PubMed         Abstract available

    BMC Public Health

  11. GOTTSCHLICH A, Rivera-Andrade A, Bevilacqua K, Murchland AR, et al
    Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    BMC Public Health. 2020;20:1406.
    PubMed         Abstract available

  12. OBOL JH, Harrison R, Lin S, Obwolo MJ, et al
    Perceptions of key informants on the provision of cervical cancer prevention and control programme in Uganda: implication for cervical cancer policy.
    BMC Public Health. 2020;20:1396.
    PubMed         Abstract available

    BMJ Open Qual

  13. TALAMA GC, Shaw M, Maloya J, Chihana T, et al
    Improving uptake of cervical cancer screening services for women living with HIV and attending chronic care services in rural Malawi.
    BMJ Open Qual. 2020;9.
    PubMed         Abstract available


  14. ABDEL-WAHAB M, Grover S, Zubizarreta EH, Polo Rubio JA, et al
    Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.
    Brachytherapy. 2020 Sep 11. pii: S1538-4721(20)30176.
    PubMed         Abstract available

  15. KUMAR R, Kala P, Narayanan GS, Vishwanathan B, et al
    Evaluation and evolution of apparent diffusion coefficient (ADC) in image-guided adaptive brachytherapy (IGABT) for cervical cancer.
    Brachytherapy. 2020 Sep 11. pii: S1538-4721(20)30175.
    PubMed         Abstract available

    Cancer Causes Control

  16. PETERSON CE, Silva A, Holt HK, Balanean A, et al
    Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review.
    Cancer Causes Control. 2020;31:801-814.
    PubMed         Abstract available

    Cancer Epidemiol

  17. LIN W, Zhou L, Hu H, Chen B, et al
    The number and gender of children synergistically impact on a mother's practice of human papillomavirus testing and attitudes towards vaccination in Shenzhen, China.
    Cancer Epidemiol. 2020;65:101682.
    PubMed         Abstract available

    Cancer Prev Res (Phila)

  18. KARPINETS TV, Solley TN, Mikkelson MD, Dorta-Estremera S, et al
    Effect of antibiotics on gut and vaginal microbiomes associated with cervical cancer development in mice.
    Cancer Prev Res (Phila). 2020 Sep 11. pii: 1940-6207.CAPR-20-0103.
    PubMed         Abstract available

    Chin Med J (Engl)

  19. CAO TT, Wen HW, Gao YN, Lyu QB, et al
    Urodynamic assessment of bladder storage function after radical hysterectomy for cervical cancer.
    Chin Med J (Engl). 2020 Sep 8. doi: 10.1097/CM9.0000000000001014.
    PubMed         Abstract available

    Clin Chim Acta

  20. PAUL DZUL S, Trinh H, Hyder J, Jang H, et al
    Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT).
    Clin Chim Acta. 2020 Sep 10. pii: S0009-8981(20)30440.
    PubMed         Abstract available

    Clin Infect Dis

  21. DEBEAUDRAP P, Sobngwi J, Tebeu PM, Clifford GM, et al
    Residual or recurrent precancerous lesions after treatment of cervical lesions in HIV-infected women: a systematic review and meta-analysis of treatment failure.
    Clin Infect Dis. 2019 Jan 2. pii: 5269500. doi: 10.1093/cid/ciy1123.
    PubMed         Abstract available

  22. HORNER MJ, Chasimpha S, Spoerri A, Edwards J, et al
    High Cancer Burden Among Antiretroviral Therapy Users in Malawi: a Record Linkage Study of Observational HIV Cohorts and Cancer Registry Data.
    Clin Infect Dis. 2018 Nov 17. pii: 5188004. doi: 10.1093.
    PubMed         Abstract available

    Eur J Cancer Prev

  23. EVERATT R, Kuzmickiene I, Intaite B, Anttila A, et al
    Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania.
    Eur J Cancer Prev. 2020 Sep 11. doi: 10.1097/CEJ.0000000000000603.
    PubMed         Abstract available

    Exp Cell Res

  24. LIU J, Zhao H, Zhang Q, Shi Z, et al
    Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
    Exp Cell Res. 2020 Sep 9:112277. doi: 10.1016/j.yexcr.2020.112277.
    PubMed         Abstract available

    Front Oncol

  25. HAN Q, Wu W, Cui Y
    LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
    Front Oncol. 2020;10:1433.
    PubMed         Abstract available

    Georgian Med News

  26. PKHAKADZE G, Bokhua Z, Asatiani T, Muzashvili T, et al
    Georgian Med News. 2020;:178-184.
    PubMed         Abstract available

    Gynecol Oncol

  27. RISCHIN D, Gil-Martin M, Gonzalez-Martin A, Brana I, et al
    PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
    Gynecol Oncol. 2020 Sep 8. pii: S0090-8258(20)33827.
    PubMed         Abstract available

  28. ADAM JA, van Diepen PR, Mom CH, Stoker J, et al
    [(18)F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature.
    Gynecol Oncol. 2020 Sep 10. pii: S0090-8258(20)33822.
    PubMed         Abstract available

    Int J Biol Markers

  29. YANG H, He K, Dong W, Fang J, et al
    PIM-1 may function as an oncogene in cervical cancer via activating the EGFR signaling.
    Int J Biol Markers. 2020 Sep 11:1724600820936295. doi: 10.1177/1724600820936295.
    PubMed         Abstract available

    Int J Clin Exp Pathol

  30. ZHANG H, Wang X, Zhang Q, Ma Y, et al
    DLEU2 participates in lymphovascular invasion and inhibits cervical cancer cell proliferation, migration, and invasion.
    Int J Clin Exp Pathol. 2020;13:2018-2026.
    PubMed         Abstract available

    Int J Clin Oncol

  31. CHOI KH, Yu M, Jeong S, Lee JH, et al
    Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Int J Clin Oncol. 2020;25:1405-1411.
    PubMed         Abstract available

    Int J Equity Health

  32. MARQUES P, Nunes M, Antunes MDL, Heleno B, et al
    Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.
    Int J Equity Health. 2020;19:160.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  33. AKILLI H, Tohma YA, Bulut AN, Atasoy Karakas L, et al
    Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors.
    Int J Gynaecol Obstet. 2020 Apr 4. doi: 10.1002/ijgo.13147.
    PubMed         Abstract available

    Int J Gynecol Cancer

  34. LI R, Germino E, Horne ZD, Vargo JA, et al
    External beam radiation and brachytherapy boost at different facilities is associated with increased treatment delays in cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 14. pii: ijgc-2020-001700.
    PubMed         Abstract available

  35. KHULPATEEA BR, Paulson A, Carlson M, Miller DS, et al
    Stage IVA cervical cancer: outcomes of disease related complications and treatment.
    Int J Gynecol Cancer. 2020 Sep 12. pii: ijgc-2019-000386.
    PubMed         Abstract available

  36. RAHMAN MS, Gultekin M, Lassi ZS
    Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic.
    Int J Gynecol Cancer. 2020 Sep 14. pii: ijgc-2020-002013.

    Int J Legal Med

  37. WEISHENG H, Shuang W, Yue L, Fang T, et al
    Fatal cervix rupture due to intraplacental choriocarcinoma triggered by sexual intercourse.
    Int J Legal Med. 2020;134:317-320.
    PubMed         Abstract available

    Int J Med Sci

  38. WANG J, Yi Y, Chen Y, Xiong Y, et al
    Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
    Int J Med Sci. 2020;17:2362-2372.
    PubMed         Abstract available

  39. KUO TN, Lin CS, Li GD, Kuo CY, et al
    Sesamin inhibits cervical cancer cell proliferation by promoting p53/PTEN-mediated apoptosis.
    Int J Med Sci. 2020;17:2292-2298.
    PubMed         Abstract available

    Int J Mol Cell Med

  40. KENARKOOHI A, Bamdad T, Soleimani M, Soleimanjahi H, et al
    HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model.
    Int J Mol Cell Med. 2020;9:146-154.
    PubMed         Abstract available

    J Cancer

  41. SONG F, Du H, Xiao A, Wang C, et al
    Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data.
    J Cancer. 2020;11:6157-6167.
    PubMed         Abstract available

  42. CHEN Q, Shi R, Liu Z, Shi Z, et al
    Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients.
    J Cancer. 2020;11:5911-5917.
    PubMed         Abstract available

  43. CHEN X, Chen L, Zhu H, Tao J, et al
    Risk factors and prognostic predictors for Cervical Cancer patients with lung metastasis.
    J Cancer. 2020;11:5880-5889.
    PubMed         Abstract available

    J Clin Med

  44. NOH JJ, Lim MC, Kim MH, Kim YH, et al
    The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer.
    J Clin Med. 2020;9.
    PubMed         Abstract available

    J Geriatr Oncol

  45. NAKAMURA R, Shimoji Y, Nakasone T, Taira Y, et al
    Relative dose intensity and overall treatment time in older patients with cervical cancer treated with concurrent chemoradiotherapy.
    J Geriatr Oncol. 2020 Sep 13. pii: S1879-4068(20)30434.

    J Infect Public Health

  46. SONG F, Du H, Xiao A, Wang C, et al
    Evaluating the performance of three di ff ;erent cervical cancer screening modalities in a large prospective population-based cohort.
    J Infect Public Health. 2020 Sep 9. pii: S1876-0341(20)30629.
    PubMed         Abstract available

    J Womens Health (Larchmt)

  47. MITCHELL EM, Lothamer H, Garcia C, Marais AD, et al
    Acceptability and Feasibility of Community-Based, Lay Navigator-Facilitated At-Home Self-Collection for Human Papillomavirus Testing in Underscreened Women.
    J Womens Health (Larchmt). 2020;29:596-602.
    PubMed         Abstract available

    JAMA Netw Open

  48. KURANI SS, McCoy RG, Lampman MA, Doubeni CA, et al
    Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.
    JAMA Netw Open. 2020;3:e200618.
    PubMed         Abstract available


  49. MABUCHI S, Matsumoto Y, Matsubara S
    A New Silicon Sling Device for Traction During Robotic Gynecologic Surgery.
    JSLS. 2020;24.
    PubMed         Abstract available

    Med Phys

  50. MORCOS M, Antaki M, Viswanathan AN, Enger SA, et al
    A novel minimally invasive dynamic shield intensity modulated brachytherapy system for cervical cancer.
    Med Phys. 2020 Sep 11. doi: 10.1002/mp.14459.
    PubMed         Abstract available

    Nurs Health Sci

  51. MAHARJAN M, Thapa N, Panthi D, Maharjan N, et al
    Health beliefs and practices regarding cervical cancer screening among women in Nepal- A descriptive cross-sectional study.
    Nurs Health Sci. 2020 Sep 12. doi: 10.1111/nhs.12775.
    PubMed         Abstract available

    Oncol Lett

  52. WAN S, Zhao H
    Analysis of diagnostic and prognostic value of lncRNA MEG3 in cervical cancer.
    Oncol Lett. 2020;20:183.
    PubMed         Abstract available

    Radiother Oncol

  53. VAN HOUDT PJ, Kallehauge JF, Tanderup K, Nout R, et al
    Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer.
    Radiother Oncol. 2020 Sep 12. pii: S0167-8140(20)30785.
    PubMed         Abstract available

    Rev Prat

  54. LEPINE C, Denize T, Badoual C
    [Vaccination against papillomavirus : outstanding issues].
    Rev Prat. 2020;70:104-108.
    PubMed         Abstract available

  55. NICAND E
    [Policies vaccination against the Human papillomavirus infections in France and worldwide].
    Rev Prat. 2020;70:90-95.
    PubMed         Abstract available

  56. PRETET JL, Selmani Z, Mougin C, Pepin-Puget L, et al
    [Vaccination against papillomavirus : arguments and evidence of effectiveness].
    Rev Prat. 2020;70:99-103.
    PubMed         Abstract available

    Sex Transm Infect

  57. GUTHRIE BL, Rositch AF, Cooper JA, Farquhar C, et al
    Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
    Sex Transm Infect. 2020;96:457-463.
    PubMed         Abstract available

  58. NEMESIO I, Cury F, Longatto-Filho A, Fregnani JH, et al
    Identification of human papillomavirus in oral rinse specimens from women with and without cervical intraepithelial lesions.
    Sex Transm Infect. 2020;96:408-410.
    PubMed         Abstract available

    South Afr J HIV Med

  59. MAKHUBO MT, Naidoo TD
    Healthcare worker compliance with cervical cancer screening guidelines. An audit at district and regional level of care in the Pietermaritzburg Metropolitan area of KwaZulu-Natal.
    South Afr J HIV Med. 2020;21:1104.
    PubMed         Abstract available

    Taiwan J Obstet Gynecol

  60. KENGSAKUL M, Manchana T
    Coexisting cancers with atypical glandular abnormalities by liquid-based cytology: A retrospective study in tertiary hospital in a high cervical cancer incident country.
    Taiwan J Obstet Gynecol. 2020;59:665-668.
    PubMed         Abstract available

    Virchows Arch

  61. D'ALESSANDRIS N, Palaia I, Pernazza A, Tomao F, et al
    PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer.
    Virchows Arch. 2020 Sep 11. pii: 10.1007/s00428-020-02922.
    PubMed         Abstract available

    Zhonghua Bing Li Xue Za Zhi

  62. CHEN L, Liu YX, Zhao CQ
    [The developments of cervical gastric-type adenocarcinoma and its spectrum lesions].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:861-866.

  63. MA DY, Dong Y, Feng H, Wang TT, et al
    [Analysis of factors influencing the false-negative diagnosis of cervical/vaginal liquid based cytology].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:806-811.
    PubMed         Abstract available

  64. WANG LQ, Wang Y, Jin W, Ding XH, et al
    [Comparison of the clinicopathological features between adenoid basal cell carcinoma and adenoid cystic carcinoma of the cervix].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:800-805.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.